(redirected from prognostic marker)
Also found in: Dictionary, Medical, Legal, Financial, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for marker

some conspicuous object used to distinguish or mark something

a writing implement for making a mark

References in periodicals archive ?
Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.
NPs are helpful for monitoring disease course and risk stratification in HF patients because they are independent prognostic markers in HF and myocardial infarction patients.
Various prognostic markers to assess the severity of AP have been evaluated.
Core to peripheral temperature gradient measurement is a simple and non-invasive technique to assess the state of peripheral circulation and has been reported by the previous studies too as a good indicator of haemodynamic status and prognostic marker of outcome.
sup][8],[9],[10] In cardiac surgery, elevation of PCT has been observed postoperatively in the absence of any evidence of infection and also appears to be a good prognostic marker.
Table-I: Evaluation of RA diagnostic and prognostic marker.
However, subsequent studies showed that association between mutation status and CD38 expression level was not absolute and that CD38 expression should be considered as an independent prognostic marker in CLL.
Subsequently, an international Ki-67 in breast cancer working group was set up in 2010 to examine the value of Ki-67 as a reproducible prognostic marker and to address the problems of methodology.
We believe that the candidate prognostic marker should be checked to distinguish malignant from benign SFTs.
The present study was conducted to evaluate the role of serum HsCRP as a prognostic marker in elderly patients presenting with sepsis.
Tumor size is a good prognostic marker for distant relapse in lymph node negative patients, although patients with small tumors (< 1 cm), left untreated, have approximately a 12% chance of recurrence.
The main focus has been to determine the patterns of molecular level alterations in p16 gene in human ovarian cancers to explore the possibilities of identifying potential biomarker in blood which could help in clinical practice as a diagnostic and prognostic marker.